Indraprastha Medical Corporation Ltd (INDRAMEDCO)
₹364.60
Mkt cap
₹3,534 Cr
P/E ratio
19.20
P/B
4.51
Div yield
1.17%
ROE
27.50%
ROCE
35.80%
EPS (TTM)
₹18.99
Book value
₹81
52W range
350–623
Sector
Healthcare
Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]
Health check
Constructive
ValuationCheap
ProfitabilityStrong
GrowthModerate
TechnicalsBearish
52-week range
−41.46% from high₹365
₹350+4.32% from low₹623
Current
₹364.60
Prev close
₹365.00
Day
−0.11%
Price performance
1D
−0.11%
1W
−2.66%
1M
−5.41%
3M
−10.30%
6M
−5.48%
1Y
−24.79%
YTD
−19.95%
Financials
FRevenue, profit & margin
P/E ratio
19.2×
INDRAMEDCO is 60% below the sector median of 47.7×
INDRAMEDCO19.2×
Sector median47.7×
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 274 | 307 | 317 | 306 | 315 | 348 | 350 | 325 | 334 | 365 | 381 | 372 | 365 | |
| Expenses | 241 | 259 | 267 | 259 | 266 | 281 | 286 | 273 | 272 | 292 | 310 | 310 | 304 | |
| Operating Profit | 33 | 47 | 50 | 47 | 48 | 67 | 64 | 52 | 61 | 73 | 71 | 62 | 61 | |
| OPM % | 12% | 15% | 16% | 15% | 15% | 19% | 18% | 16% | 18% | 20% | 19% | 17% | 17% | |
| Other Income | 5 | 4 | 4 | 4 | 5 | 5 | 6 | 5 | 6 | 7 | 7 | 7 | 7 | |
| Interest | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 1 | |
| Depreciation | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 10 | 11 | 11 | 11 | |
| Profit before tax | 27 | 40 | 44 | 41 | 42 | 60 | 57 | 45 | 55 | 68 | 66 | 56 | 55 | |
| Tax % | 27% | 24% | 25% | 28% | 25% | 25% | 26% | 26% | 26% | 25% | 25% | 27% | 24% | |
| Net Profit | 20 | 30 | 33 | 29 | 31 | 45 | 42 | 33 | 41 | 51 | 49 | 41 | 42 | |
| EPS in Rs | 2.16 | 3.33 | 3.58 | 3.21 | 3.40 | 4.88 | 4.63 | 3.58 | 4.47 | 5.61 | 5.40 | 4.47 | 4.55 | |
| Raw PDF |
Earnings
EResults dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
CLast 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
Sas of Mar 202651.00%Promoter
Promoters51.00%
FIIs2.43%0.29
DIIs0.87%0.05
Public45.69%0.26
Ownership trend
Peers
P8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,592.00 | 63.17 | 1,23,540 | 0.22% | 551 | +35.86% | 6,606 | +18.12% | 17.89% |
| Max Healthcare | ₹1,123.35 | 73.68 | 1,09,329 | 0.18% | 342 | +7.28% | 2,143 | +12.21% | 14.72% |
| Fortis Health. | ₹954.80 | 68.08 | 72,083 | 0.10% | 271 | +22.42% | 2,365 | +17.81% | 13.47% |
| Narayana Hrudaya | ₹1,956.80 | 46.95 | 39,989 | 0.23% | 224 | +12.47% | 2,594 | +75.80% | 15.36% |
| Aster DM Health. | ₹769.05 | 97.62 | 39,846 | 0.65% | 154 | +41.97% | 1,182 | +18.20% | 11.40% |
| Global Health | ₹1,312.40 | 63.32 | 35,287 | 0.04% | 142 | +4.71% | 1,159 | +24.46% | 17.14% |
| Krishna Institu. | ₹795.35 | 134.69 | 33,405 | 0.00% | 33 | −50.66% | 1,075 | +34.85% | 9.29% |
| Indrapr.Medical | ₹385.45 | 19.24 | 3,534 | 1.17% | 42 | +1.68% | 365 | +9.31% | 35.83% |
| Median: 28 Co. | ₹529.83 | 47.69 | 5,359 | 0.02% | 31 | +22.42% | 353 | +22.28% | 14.76% |
Filings
DAnnual reports15
Financial Year 2025bseFinancial Year 2024bseFinancial Year 2023bseFinancial Year 2022bseFinancial Year 2021bseFinancial Year 2020bseFinancial Year 2019bseFinancial Year 2018bseFinancial Year 2017bseFinancial Year 2016bseFinancial Year 2014bseFinancial Year 2013bseFinancial Year 2012bseFinancial Year 2012nseFinancial Year 2011bse
Credit ratings6
Announcements5
Closure of Trading Window 24 JunAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 2 JunAnnouncement under Regulation 30 (LODR)-Credit Rating 27 May - ICRA reaffirmed IMCL’s [ICRA]AA(Stable) and [ICRA]A1+ ratings for Rs162.5 crore facilities.Announcement under Regulation 30 (LODR)-Newspaper Publication 13 May - We hereby submit copies of the public notice of the financial results, published on 13th May, 2026, in the "Financial Express", all India editions, in …Board Meeting Outcome for OUTCOME OF THE BOARD MEETING 12 May - Company confirms it does not qualify as a Large Corporate under SEBI circulars.







